Autopsies show coronavirus lingers in brain, other parts for months: Study

The SARS-CoV-2 virus spreads throughout the body, including the brain, and lingers for almost eight months, shows an analysis of tissue samples from the autopsies of people who died due to Covid-19

coronavirus, testing
Press Trust of India Washington
2 min read Last Updated : Jan 03 2023 | 12:54 PM IST

The SARS-CoV-2 virus spreads throughout the body, including the brain, and lingers for almost eight months, shows an analysis of tissue samples from the autopsies of people who died due to COVID-19.

The researchers from the US National Institutes of Health (NIH) tested samples from autopsies that were performed from April 2020 to March 2021. They conducted extensive sampling of the nervous system, including the brain, in 11 of the patients. All of the patients died with COVID-19, and none were vaccinated.

The blood plasma of 38 patients tested positive for SARS-CoV-2, three tested negative, and plasma was unavailable for the other three.

Thirty per cent of the patients were female, and the median age was 62.5 years. Twenty-seven patients (61.4 per cent) had three or more comorbidities.

The median interval from symptom onset to death was 18.5 days.

The study, published in the journal Nature, showed that SARS-CoV-2 primarily infected and damaged airway and lung tissue.

However, the researchers also found viral RNA in 84 distinct body locations and bodily fluids, and in one case they isolated viral RNA 230 days after a patient's symptoms began.

They detected SARS-CoV-2 RNA and protein in the hypothalamus and cerebellum of one patient and in the spinal cord and basal ganglia of two other patients.

However, the study found little damage to brain tissue, "despite substantial viral burden."

The researchers also isolated viable SARS-CoV-2 virus from diverse tissues in and outside the respiratory tract, including the brain, heart, lymph nodes, gastrointestinal tract, adrenal gland, and eye.

They isolated virus from 25 of 55 specimens tested (45 per cent).

"We demonstrated virus replication in multiple non-respiratory sites during the first two weeks following symptom onset," the authors of the study noted.

Prior to this study, "the thinking in the field was that SARS-CoV-2 was predominantly a respiratory virus," senior study author Daniel Chertow from NIH added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirusscience research

First Published: Jan 03 2023 | 12:54 PM IST

Next Story